Clinical Trial Update: A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries [Phase 1, Phase 2]

View source ↗

Summary

The trial update reports completed Phase 1/2 safety studies of Cethrin (BA-210) for acute thoracic and cervical spinal cord injuries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Cethrin

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Spinal Cord Injury | Phase 1, Phase 2 | Status: COMPLETED